FBXO42は,p57Kip2のユビキチン化と分解を介し,肝細胞がんの進行を促進する
Bing Zhou1, Shasha Wu2, Shengqian Hong3
1Department of General Surgery, The First Affiliated Hospital of Soochow University, No. 899, Pinghai Road, Suzhou, 215031, Jiangsu, China.
European journal of medical research
|August 22, 2025
まとめ
FBXO42は,p57Kip2を分解することによって,肝細胞癌 (HCC) の悪性腫瘍を促進する. FBXO42を標的とした治療は,HCC患者にとって新しい治療戦略となるかもしれません.
科学分野:
- 腫瘍学
- 分子生物学
- 免疫学
背景:
- 肝臓細胞癌 (HCC) は悪性腫瘍の1つで,肝臓がんの原発は約80%を占める.
- FBXO42は,Fボックスタンパク質であり,SCFユビキチンリガゼ複合体の構成要素であり,タンパク質のユビキチン化に不可欠である.
- FBXO42の様々な疾患,特にHCCにおける役割に関する研究は限られている.
研究 の 目的:
- 肝細胞癌 (HCC) でのFBXO42の発現,臨床的意義,機能的役割を調査する.
- FBXO42がHCCの進行に関与する分子メカニズムを解明する.
- FBXO42をHCCの潜在的治療標的として評価する.
主な方法:
- 公的データベース (HCCDB,TCGA,ICGC,cBioPortal,SangerBox,TIMER,TISIDB,GEPIA) を利用して,FBXO42の発現,遺伝子変異,および臨床的特徴と腫瘍の微環境との相関性を分析した.
- 細胞の生存,増殖,移動を評価するために,in vitroアッセイ (CCK8,クローン形成,EDU,トランスウェル) を実施した.
- FBXO42相互作用タンパク質 (p57Kip2) と転写レギュレータ (YY1) を共免疫降水およびバイオインフォマティックツールを用いて特定した.
主要な成果:
- FBXO42はHCCの組織に高度に発現し,予後不良,免疫細胞の浸透,がん幹と相関しています.
- FBXO42はHCC細胞の生存能力,増殖,移動,悪性行動を強化する.
- FBXO42は,ユビキチン化と分解のためのp57Kip2を標的とし,HCCの進行を促進し,YY1によって転写上調節されます.
結論:
- FBXO42はp57Kip2のユビキチン化と分解を介してHCCの悪性腫瘍を促進し,HCCの複雑な免疫マイクロ環境におけるその役割を強調しています.
- FBXO42は肝細胞がんの治療に有望な標的である.
- YY1を含むFBXO42の規制ネットワークを理解することは,標的型HCC治療の開発に不可欠です.
関連する概念動画
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K
NF-κB-dependent Signaling Pathway
7.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.8K
Liver Regeneration
3.4K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.4K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Interactions Between Signaling Pathways
6.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K


